Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 20
- Q4 2024, −2 vs. previous quarter
- 13F value
- $21.5M
- Reported value at the end of Q4 2024
- Superinvestors holding
- 0
- At the end of Q4 2024
Superinvestors holding OMIC, Q4 2024
No superinvestor reported holding OMIC at the end of Q4 2024.
Latest insider trades
Open-market purchases and sales by Singular Genomics Systems, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 (view filing) | Feb 14 | Same day | Spaventa AndrewChief Executive Officer | SSale | −800 | $19.89 | −$15.9K | −35.8%1.43K after | |
| Dec 17, 2024 (view filing) | Dec 16 | 1 day | Spaventa AndrewChief Executive Officer | SSale | −180 | $20.16 | −$3.63K | −22.2%631 after | |
| Nov 13, 2024 (view filing) | Nov 12 | 1 day | Spaventa AndrewChief Executive Officer | SSale | −695 | $22.55 | −$15.7K | −31.1%1.54K after | |
| Sep 18, 2024 (view filing)4:31 PM ET | Sep 16-18 | 2 days | Tang Kevin C and 2 others10% Owner | PPurchase | +122.4K | $14.75 | +$1.81M | +49.0%372.0K after | 3 lots |
| Sep 17, 2024 (view filing) | Sep 15 | 2 days | Spaventa AndrewChief Executive Officer | SSale | −175 | $12.38 | −$2.17K | −21.6%637 after | |
| Nov 20, 2023 (view filing)4:31 PM ET | Nov 16-17 | 4 days | Spaventa AndrewChief Executive Officer | PPurchase | +118.5K | $0.4188 | +$49.6K | +3.0%4.06M after | 2 lots |
| Nov 20, 2023 (view filing)4:30 PM ET | Nov 16 | 4 days | Glezer Eli N.Chief Scientific Officer | PPurchase | +200.0K | $0.4282 | +$85.6K | +4.6%4.57M after | |
| Aug 15, 2023 (view filing) | Aug 11-15 | 4 days | Kamdar Kim P.Director | SSale | −631.6K | $0.5741 | −$362.6K | −14.4%3.76M after | 3 lots |
| May 18, 2023 (view filing) | May 17 | 1 day | Glezer Eli N.Chief Scientific Officer | PPurchase | +170.0K | $0.82 | +$139.4K | +4.1%4.36M after | |
| Dec 13, 2022 (view filing) | Dec 12 | 1 day | Glezer Eli N.Chief Scientific Officer | PPurchase | +50.0K | $2.00 | +$100.0K | +1.2%4.18M after |
Top 10 13F holders, Q4 2024
The largest institutional positions in Singular Genomics Systems, Inc. at the end of Q4 2024; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 372,000 | $7.23M | 0.48% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 166,162 | $3.23M | 0.06% | 00.0% | Unchanged |
| UBS Group AG | 156,254 | $3.04M | 0.00% | +78,270+100.4% | Added |
| ARCH Venture Management, LLC | 126,630 | $2.46M | 1.07% | 00.0% | Unchanged |
| QVIDTVM Management LLC | 83,671 | $1.63M | 1.31% | +113+0.1% | Added |
| FMR LLC | 70,653 | $1.37M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 62,418 | $1.21M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 17,990 | $349.8K | 0.00% | +28+0.2% | Added |
| HighTower Advisors, LLC | 17,607 | $342.1K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 15,165 | $294.7K | 0.00% | −569−3.6% | Reduced |